Calling it the “next concerning challenge”, which needs to be tackled, Poonawalla posted a tweet tagging the Prime Minister’s Office, which read: “We need to plan and guide vaccine manufacturers both in India and overseas to service the needs of our country in terms of procurement and distribution.”
Serum has tie ups with global manufacturers AstraZeneca and Novavax for potential Covid-19 vaccines, which are currently undergoing clinical trials. The tweet, perceived by many as alarming, also raised concerns over the government’s ability to fund the massive vaccine programme.
“The government has assured that there will be plenty of funds available for vaccines. We have now been assured by the highest levels in the government that enough funds will be available for vaccine procurement, supply and logistics. This is good news,” Poonawalla told TOI, when contacted.
While addressing the United Nations General Assembly on Saturday PM Modi said that as the world’s largest vaccine producing country, India’s vaccine production and delivery capacity will be used to help people across the world.
Although further details on Poonawala’s calculations were not immediately available, sources said, it could be assuming the benchmark price of $3-5 per dose, and including two doses for the over 1.3 billion population.